248 related articles for article (PubMed ID: 11697293)
1. [Strathmann AG: first OTC, now biotechnology. AIDS vaccines from German biotechnology research? (interview by Dr. med. Dirk Einecke)].
Strathmann G
MMW Fortschr Med; 2001 Oct; 143(42):58-9. PubMed ID: 11697293
[No Abstract] [Full Text] [Related]
2. The art of self-defence.
Gewin V
Nature; 2008 Mar; 452(7186):498-500. PubMed ID: 18444262
[No Abstract] [Full Text] [Related]
3. [New developments also in general medicine. GSK relies on research as well as transparent collaboration with physicians (interview by Dirk Einecke, Wolfgang van den Bergh, Peter Overbeck and Cornelius Heyer)].
Marshall CG; Strohmeyer T
MMW Fortschr Med; 2011 May; 153(21):10-1. PubMed ID: 21739676
[No Abstract] [Full Text] [Related]
4. Editorial: Biotechnology in Korea--the next generation growth engine.
Lee SY
Biotechnol J; 2008 May; 3(5):562-3. PubMed ID: 18481356
[No Abstract] [Full Text] [Related]
5. Intercell - accelerating innovation.
Brehme M
N Biotechnol; 2009 Apr; 25(4):181-4. PubMed ID: 19429533
[TBL] [Abstract][Full Text] [Related]
6. GlaxoSmithKline pushes its labs towards 'biotech' future.
Adam D
Nature; 2001 Mar; 410(6824):5. PubMed ID: 11242002
[No Abstract] [Full Text] [Related]
7. Evolution and future of biopharmaceuticals.
Health Aff (Millwood); 2006; 25(5):1270. PubMed ID: 16966722
[No Abstract] [Full Text] [Related]
8. Industrial strength research. Collaborative efforts in AIDS vaccine research are adopting some characteristics common in the biopharmaceutical industry.
Zandonella C
IAVI Rep; 2006; 10(1):1, 6-8. PubMed ID: 16625718
[No Abstract] [Full Text] [Related]
9. A new formula for finding drugs.
Davies N; Peakman T; Arlington S
Drug Discov Today; 2004 Mar; 9(5):197-9. PubMed ID: 14980535
[No Abstract] [Full Text] [Related]
10. Profiles of four top biotech companies in India.
Suresh N; Rao ChS
Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
[No Abstract] [Full Text] [Related]
11. [Which herbal drugs can be trusted? Herbal drugs increasingly from the supermarket (interview by Dr. med. Dirk Einecke)].
Dingermann T
MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():24. PubMed ID: 22916421
[No Abstract] [Full Text] [Related]
12. Perspectives: biotechnology in Czech Republic, the past and the future.
Damborský J; Prokop Z; Kostka M
Biotechnol J; 2006 May; 1(5):487-90. PubMed ID: 16892283
[No Abstract] [Full Text] [Related]
13. [Medicine needs new concepts. Prevention for the future (interview by Dr. Dirk Einecke)].
Maar C
MMW Fortschr Med; 2004 Jul; 146(27-28):50-1. PubMed ID: 15526669
[No Abstract] [Full Text] [Related]
14. Strategic considerations for the biotechnology business to the year 2000.
Cometta S
Arzneimittelforschung; 1989 Aug; 39(8):929-34. PubMed ID: 2818683
[TBL] [Abstract][Full Text] [Related]
15. Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice.
Piascik P
Pharm Pract Manag Q; 1998 Jul; 18(2):1-12. PubMed ID: 10185234
[TBL] [Abstract][Full Text] [Related]
16. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
17. A brave new medicine. A conversation with William Haseltine.. Interview by Joe Flower.
Hasetine W
Health Forum J; 1999; 42(4):28-30, 61-5. PubMed ID: 10539016
[No Abstract] [Full Text] [Related]
18. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
Tear S; Zarkowska T
IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
[No Abstract] [Full Text] [Related]
19. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
20. Innovation in biotechnology: current and future states.
Woollett GR
Clin Pharmacol Ther; 2012 Jan; 91(1):17-20. PubMed ID: 22179626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
